| |
| | MAPS: Psychedelic Research with MDMA MDE LSD Ayahuasca Ibogaine Ketamine DMT Psilocybin Peyote Salvia divinorum |
 | | After psilocybin, 61% of the volunteers met pre-established criteria, as measured on standardized scales, for a full mystical experience, and 31% reported significant fear sometime during their psilocybin session. |
 | | This is a randomized, double-blind, active placebo-controlled study of the effects of medium doses of psilocybin in 12 healthy physicians, examining the effects of psilocybin on different neuropsychological measures, perceptual changes, synaesthesias and some subjective effects. |
 | | The researchers assessed subjective, physiological and neuroendocrine effects of psilocybin, including an assessment of attention and visual perception, and previous investigations have examined the contribution of serotonin and dopamine transmitter sytsems to producing the subjective effects of psilocybin. |
| www.maps.org /research (7680 words) |
|